Skip main navigation

Military Health System

Hurricane Milton & Hurricane Helene

Emergency procedures are in place in multiple states due to Hurricane Milton & Hurricane Helene. >>Learn More

Innovative RX pad creates path for prescribing mobile health technology

Image of Innovative RX pad creates path for prescribing mobile health technology. Innovative RX pad creates path for prescribing mobile health technology

Technology expands the patient provider connection and the ability to continue treatment during difficult times when in person access is limited. Defense Health Agency Connected Health’s Education and Training team works to create tools that will bring mobile health technology to patient care. 

During COVID-19, with states under stay-at-home orders and regular office visits having turned virtual, a provider may be thinking, “How do I begin integrating technology with traditional care?” Many providers are uncertain of how to bridge the technology health gap with their patients. Now, health professionals can use a customized RX pad to formally prescribe mobile health apps to enhance their patient’s treatment plan. Health providers can download the DHA health technology prescription pad from the DHA Connected Health Education and Training website at http://health.mil/mHealthTraining.

DHA Connected Health Education and Training saw a need to help military providers find a trusted way to use mobile health technologies with their patients. The prescription pad enables providers to quickly locate DHA and Department of Veteran Affairs approved mobile health apps. 

“It can be difficult for busy care teams to identify safe and evidence-based health technology to support health issues common in the military community,” said Julie Kinn, DHA Connected Health Education and Training lead. “We wanted to make an easy-to-use resource that can help providers find good tools and make it easy to share these resources with their patients.” 

As healthcare providers begin integrating technology, they may have questions about how to prescribe mobile apps in treatment. 

“My recommendation is to be specific about the timing and how often the patient will use the technology,” Kinn said. “These are guidelines that will benefit both patient and provider as clinical care progresses.”

The prescription pad includes a choice of 24 mobile apps covering topics from mindfulness to post-traumatic stress disorder and mood tracking. Prescribing mobile apps allows a patient to work with a provider on an ongoing basis without being in the same location. This convenience helps to keep the service member on track and involved with a provider even while deployed. The back of the prescription pad provides patients with several additional support and informational resources.

When patients engage with prescribed mobile apps during treatment, they take an active role in their own care. Some studies show patient engagement leads to better health results overall.  

T2 Mood Tracker, for example, allows a patient to track emotions over time and enables the provider to see developing patterns through a report generator. Another highly-rated mobile app is the Virtual Hope Box, which helps patients with positive coping and emotion regulating skills. Patients can personalize the app with their family photos, media, personal messages, inspirational quotes, and music, allowing them to complete meaningful homework assignments between provider visits. Connecting service members to a hopeful experience is the goal.

Technology and healthcare are constantly evolving fields, Kinn said, and DHA Connected Health’s Education and Training program continues to look for ways to support the military health provider with new tools and resources.

You also may be interested in...

Report
Jan 1, 2017

MSMR Vol. 24 No. 2 - February 2017

.PDF | 1.31 MB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Incident diagnoses of leishmaniasis, active and reserve components, U.S. Armed Forces, 2001–2016; Incidence rates of malignant melanoma in relation to years of military service, overall and in selected ...

Report
Jan 1, 2017

MSMR Vol. 24 No. 3 - March 2017

.PDF | 1.60 MB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Diagnoses of traumatic brain injury not clearly associated with deployment, active component, U.S. Armed Forces, 2001–2016; Update: Heat illness, active component, U.S. Armed Forces, 2016; Update: Exertional ...

Report
Jan 1, 2017

MSMR Vol. 24 No. 9 - September 2017

.PDF | 1.03 MB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Review of the U.S. military's human immunodeficiency virus program: a legacy of progress and a future of promise; Update: Routine screening for antibodies to human immunodeficiency virus, civilian applicants ...

Report
Jan 1, 2017

MSMR Vol. 24 No. 8 - August 2017

.PDF | 986.46 KB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Multiple sclerosis among service members of the active and reserve components of the U.S. Armed Forces and among other beneficiaries of the Military Health System, 2007–2016; Challenges with diagnosing and ...

Report
Jan 1, 2017

MSMR Vol. 24 No. 4 - April 2017

.PDF | 1.29 MB

A monthly publication of the Armed Forces Health Surveillance Branch. This issue of the peer-reviewed journal contains the following articles: Absolute and relative morbidity burdens attributable to various illnesses and injuries, active component, U.S. Armed Forces, 2016; Hospitalizations, active component, U.S. Armed Forces, 2016; Ambulatory visits, ...

Report
May 11, 2016

Study Finds Strong Immune Response to HPV Vaccine Among Female Service Members

.PDF | 183.92 KB

A new study of female service members that examined their immune response to a vaccine to combat the sexually transmitted virus that causes cervical cancer showed development of antibodies in 80 to 99 percent of recipients against each of the four strains of the disease.

Skip subpage navigation
Refine your search
Last Updated: July 15, 2020
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery